Abstract
Based on gestational age at diagnosis and/or delivery, pre-eclampsia (PE) is commonly divided into early-onset (<34 weeks) and late-onset (≥34 weeks) forms. Recently, the distinction between ‘placental’ and ‘maternal’ causation has been proposed, with ‘placental’ cases being more frequently associated with early-onset and intrauterine growth restriction. To test whether molecular placental pathology varies according to clinical presentation, we investigated stress-signalling pathways, including unfolded protein response (UPR) pathways, MAPK stress pathways, heat-shock proteins and AMPKα in placentae delivered by caesarean section for clinical indications at different gestational ages. Controls included second-trimester, pre-term and normal-term placentae. BeWo cells were used to investigate how these pathways react to different severities of hypoxia–reoxygenation (H/R) and pro-inflammatory cytokines. Activation of placental UPR and stress-response pathways, including P-IRE1α, ATF6, XBP-1, GRP78 and GRP94, P-p38/p38 and HSP70, was higher in early-onset PE than in both late-onset PE and normotensive controls (NTCs), with a clear inflection around 34 weeks. Placentae from ≥ 34 weeks PE and NTC were indistinguishable. Levels of UPR signalling were similar between second-trimester and term controls, but were significantly higher in pre-term ‘controls’ delivered vaginally for chorioamnionitis and other conditions. Severe H/R (1/20% O2) induced equivalent activation of UPR pathways, including P-eIF2α, ATF6, P-IRE1α, GRP78 and GRP94, in BeWo cells. By contrast, the pro-inflammatory cytokines TNFα and IL-1β induced only mild activation of P-eIF2α and GRP78. AKT, a central regulator of cell proliferation, was reduced in the < 34 weeks PE placentae and severe H/R-treated cells, but not in other conditions. These findings provide the first molecular evidence that placental stress may contribute to the pathophysiology of early-onset pre-eclampsia, whereas that is unlikely to be the case in the late-onset form of the syndrome. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
Highlights
Pre-eclampsia (PE) affects 3–8% of pregnancies and is associated with the development of de novo hypertension, proteinuria, liver dysfunction and other systemic disturbances after 20 weeks of gestation [1]
We have recently demonstrated activation of endoplasmic reticulum (ER) stress pathways in placentae from cases of intrauterine growth restriction (IUGR), with greater activation in those complicated with pre-eclampsia (IUGR + PE) [26]
Following our previous finding of high ER stress in IUGR + PE placentae, we examined activation levels of unfolded protein response (UPR) pathways and other common stress signalling pathways, including AMP-activated protein kinase-α (AMPKα), p38–JNK stress signalling pathways and cytosolic heat shock proteins (HSPs) in placentae delivered from pre-eclamptic patients at gestational ages of 24–39 weeks
Summary
Pre-eclampsia (PE) affects 3–8% of pregnancies and is associated with the development of de novo hypertension, proteinuria, liver dysfunction and other systemic disturbances after 20 weeks of gestation [1]. There is a greater prevalence of placental lesions indicative of maternal malperfusion [8,9,10], as confirmed by a recent magnetic resonance imaging study [11] In view of these differences, it has been proposed that PE can be classified on the basis of the pathophysiology into ‘placental’ and ‘maternal’ causation [12]. In the former, it is postulated that malperfusion leads to placental stress and the release of cytokines and angiogenic regulators that cause maternal endothelial cell activation. To determine the stimulus required to generate equivalent changes in vitro, we exposed human choriocarcinoma cells (BeWo) to different severities of hypoxia–reoxygenation or treatment with pro-inflammatory cytokines
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have